rosuvastatin

(redirected from rosuvastatin calcium)
Also found in: Medical.

ro·su·va·stat·in

 (rŏ-so͞o′və-stăt′n)
n.
A statin drug, C22H28FN3O6S, used in the form of its calcium salt to lower cholesterol (especially LDL) levels and to reduce the risk of heart attack and stroke in individuals with elevated risk.

[Perhaps (fluo)ro- + su(lfonyl) + -vastatin, statin suffix; see pravastatin.]
Translations

rosuvastatin

n rosuvastatina
References in periodicals archive ?
The company received the US FDA approval for the cholesterol reducing drug Rosuvastatin Calcium. The usage of statin classes of cholesterol reducing agents has increased steadily over the last five years.
It received clearance for the following: potassium chloride extended-release tablets USP, 10 mEq (750 mg) and 20 mEq (1,500 mg), the generic version of K-Dur; triamcinolone acetonide cream USP 0.1% and for the 0.5% ointment; and rosuvastatin calcium tablets in 5, 10, 20 and 40 mg bases.
Rosuvastatin calcium tablets (Crestor 5 mg, AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA) were mixed at a proportion of 1 tablet per 0.9 mL of distilled water and vortexed for 5 minutes to obtain a concentration of 5 mg/mL (considering the added volume of the tablets).
Certriad (rosuvastatin calcium and fenofibric acid) was being studied for the treatment of mixed dyslipidemia.
Crestor (rosuvastatin calcium), a prescription drug for treating high cholesterol, is manufactured by AstraZeneca and sold in over 60 countries.
In the case of Crestor (rosuvastatin calcium), the application for approval was one of the most extensive ever for a statin involving more than 12,000 patients, and was also unanimously recommended for approval by the FDA's advisory board in July of 2003.
The same has been true for Crestor (rosuvastatin calcium), AstraZeneca PLC's new drug for lowering cholesterol, according to Ryan.
M2 EQUITYBITES-July 25, 2016-Citron Pharma receives US FDA Abbreviated New Drug Application approval for Rosuvastatin Calcium 5, 10, 20 and 40 mg tablets
M2 PHARMA-July 25, 2016-Citron Pharma receives US FDA Abbreviated New Drug Application approval for Rosuvastatin Calcium 5, 10, 20 and 40 mg tablets